Polymorphic acetylation of drugs in rabbits.
D000107:Acetylation; D062365:Aminobenzoates / Q000378:metabolism; D000636:Aminosalicylic Acids / Q000378:metabolism; D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D002855:Chromatography, Thin Layer; D003622:Dapsone / Q000378:metabolism; D005260:Female; D005838:Genotype; D006207:Half-Life; D006830:Hydralazine / Q000378:metabolism; D007421:Intestine, Small / Q000378:metabolism; D007538:Isoniazid / Q000378:metabolism; D007928:Lethal Dose 50; D008099:Liver / Q000378:metabolism; D008297:Male; D008708:Methemoglobinemia / Q000139:chemically induced; D010641:Phenotype; D011110:Polymorphism, Genetic; D011817:Rabbits / Q000378:metabolism*; D013329:Structure-Activity Relationship; D013418:Sulfamethazine / Q000378:metabolism*; D013424:Sulfanilamides / Q000378:metabolism; D013997:Time Factors
D062365:Aminobenzoates; D000636:Aminosalicylic Acids; D013424:Sulfanilamides; D006830:Hydralazine; D013418:Sulfamethazine; D003622:Dapsone; D007538:Isoniazid